Evidence map›Paper›PMID 19730693›Full record

ArticlePLoS pathogens2009

CD8(+) T cells restrict Yersinia pseudotuberculosis infection: bypass of anti-phagocytosis by targeting antigen-presenting cells.

Molly A Bergman, Wendy P Loomis, Joan Mecsas, Michael N Starnbach, Ralph R Isberg

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Increased Motility inInternational journal of molecular sciences · 2024
    Article
  3. AApplied and environmental microbiology · 2023
    Article
  4. Article
  5. Heightened Virulence ofInfection and immunity · 2021
    Article
  6. Article
  7. Review
  8. Review
  9. CCR2Infection and immunity · 2018
    Article
  10. Article
  11. Review
  12. Article
  13. Frontiers in microbiology · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. CD8(+) T cells specific to a single Yersinia pseudotuberculosis epitope restrict bacterial replication in the liver but fail to provide sterilizing immunity.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2016
    Article
  19. Rapid CD8Frontiers in pediatrics · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Molly A BergmanDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America.
Wendy P Loomis
Joan Mecsas
Michael N Starnbach
Ralph R Isberg
Harvard University · USTufts University · USHoward Hughes Medical Institute · US

Funding

Cytotoxic T Cell Mediated Immunity to ChlamydiaR01AI039558 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI STARNBACH, MICHAEL N · 2001 to 2025
$15.6M
PILOT AND FEASIBILITY STUDIESP30DK034928 · NIDDK · TUFTS MEDICAL CENTER · PI PLAUT, ANDREW GEORGE · 1986 to 2007
$8.5M
MOLECULAR BASIS OF YERSINIA/HOST CELL INTERACTIONR37AI023538 · NIAID · TUFTS UNIVERSITY BOSTON · PI ISBERG, RALPH R. · 2000 to 2009
$3.3M
Inhibition of T Cell Responses by BacteriaR01AI055962 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI STARNBACH, MICHAEL N · 2003 to 2010
$2.7M
Yersinia Yops in an Animal Infection ModelR01AI056068 · NIAID · TUFTS UNIVERSITY BOSTON · PI MECSAS, JOAN C. · 2003 to 2007
$1.8M
CYTOTOXIC T CELL MEDIATED IMMUNITY TO CHLAMYDIAR29AI039558 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI STARNBACH, MICHAEL N · 1996 to 2000
$135k
BHP HRSA HHS PF0325701MBCHoward Hughes Medical Institute AI055962Howard Hughes Medical Institute AI056068Howard Hughes Medical Institute AI39558Howard Hughes Medical Institute R37AI23538NIAID NIH HHS R01 AI039558NIAID NIH HHS R01 AI055962NIAID NIH HHS R01 AI056068NIAID NIH HHS R29 AI039558NIAID NIH HHS R37 AI023538NIDDK NIH HHS P30 DK034928NIDDK NIH HHS P30DK34928
6 · The paper itself

Abstract

All Yersinia species target and bind to phagocytic cells, but uptake and destruction of bacteria are prevented by injection of anti-phagocytic Yop proteins into the host cell. Here we provide evidence that CD8(+) T cells, which canonically eliminate intracellular pathogens, are important for restricting Yersinia, even though bacteria are primarily found in an extracellular locale during the course of disease. In a model of infection with attenuated Y. pseudotuberculosis, mice deficient for CD8(+) T cells were more susceptible to infection than immunocompetent mice. Although exposure to attenuated Y. pseudotuberculosis generated T(H)1-type antibody responses and conferred protection against challenge with fully virulent bacteria, depletion of CD8(+) T cells during challenge severely compromised protective immunity. Strikingly, mice lacking the T cell effector molecule perforin also succumbed to Y. pseudotuberculosis infection. Given that the function of perforin is to kill antigen-presenting cells, we reasoned that cell death marks bacteria-associated host cells for internalization by neighboring phagocytes, thus allowing ingestion and clearance of the attached bacteria. Supportive of this model, cytolytic T cell killing of Y. pseudotuberculosis-associated host cells results in engulfment by neighboring phagocytes of both bacteria and target cells, bypassing anti-phagocytosis. Our findings are consistent with a novel function for cell-mediated immune responses protecting against extracellular pathogens like Yersinia: perforin and CD8(+) T cells are critical for hosts to overcome the anti-phagocytic action of Yops.

Indexed as

AnimalsAntigen-Presenting CellsBacterial VaccinesCD8-Positive T-LymphocytesDisease Models, AnimalHost-Pathogen InteractionsImmunoglobulin GKaplan-Meier EstimateLiverLymphoid TissueMiceMice, Inbred C57BLPhagocytosisPore Forming Cytotoxic ProteinsStatistics, NonparametricT-Lymphocytes, CytotoxicBacterial VaccinesImmunoglobulin Gperforin, mousePore Forming Cytotoxic ProteinsVaccines, Attenuated

Identifiers

PMID19730693
PMCPMC2731216
OpenAlexW2170917265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.